Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

New findings on hair keratin, wound healing, and skin blistering were presented.

Topical Ruxolitinib may safely treat severe hair loss.

Recombinant keratin K31 makes damaged hair thicker, stronger, and straighter.

Wnt10b makes hair follicles bigger, but DKK1 can reverse this effect.

KAP8.1 protein is crucial for hair structure and interacts with keratin 85.

Blocking JAK-STAT signaling can lead to hair growth.

SKO-derived SKP-like cells may help with hair regeneration and skin restoration.

Hair follicle stem cells help maintain skin health by moving to and supporting the skin's surface layers.

Mice with human-like EGFR had growth issues, skin defects, heart problems, and unusual bone development.

Scientists used stem cells to create a model of the skin disease Epidermolysis Bullosa simplex, which helped them understand its molecular mechanisms and could aid in finding treatments.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

KY19382 speeds up wound healing by activating a specific cell signaling pathway.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Keratin-associated proteins have ancient origins and were used for different purposes before being adapted for hair in mammals.

A new method was developed to create complex molecular knots using iron ions.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

The document's conclusion cannot be provided as the document is not accessible or cannot be parsed.

Human hair proteins can be used to create scaffolds that support cell growth for tissue engineering.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.